Literature DB >> 16984418

Inactivation of Bacillus anthracis spores in murine primary macrophages.

Haijing Hu1, Qila Sa, Theresa M Koehler, Arthur I Aronson, Daoguo Zhou.   

Abstract

The current model for pathogenesis of inhalation anthrax indicates that the uptake and fate of Bacillus anthracis spores in alveolar macrophages are critical to the infection process. We have employed primary macrophages, which are more efficient for spore uptake than the macrophage-like cell line RAW264.7, to investigate spore uptake and survival. We found that at a multiplicity of infection (moi) of 5, greater than 80% of the spores of the Sterne strain containing only the pXO1 plasmid were internalized within 1 h. Within 4 h post infection, viability of internalized Sterne spores decreased to approximately 40%. Intracellular vegetative bacteria represented less than 1% of the total spore inoculum throughout the course of infection suggesting effective killing of germinated spores and/or vegetative bacteria. The Sterne spores trafficked quickly to phagolysosomes as indicated by colocalization with lysosome-associated membrane protein 1 (LAMP1). Expression of a dominant-negative Rab7 that blocked lysosome fusion enhanced Sterne spore survival. Addition of d-alanine to the infection resulted in 75% inhibition of spore germination and increased survival of internalized spores of the Sterne strain and a pathogenic strain containing both the pXO1 and pXO2 plasmids. Inhibition was reversed by the addition of l-alanine, which resumed spore germination and subsequent spore killing. Our data indicate that B. anthracis spores germinate in and are subsequently killed by primary macrophages.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984418     DOI: 10.1111/j.1462-5822.2006.00738.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  40 in total

1.  Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.

Authors:  Shihui Liu; Sharmina Miller-Randolph; Devorah Crown; Mahtab Moayeri; Inka Sastalla; Shu Okugawa; Stephen H Leppla
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

2.  Tracking bacterial infection of macrophages using a novel red-emission pH sensor.

Authors:  Yuguang Jin; Yanqing Tian; Weiwen Zhang; Sei-Hum Jang; Alex K-Y Jen; Deirdre R Meldrum
Journal:  Anal Bioanal Chem       Date:  2010-08-19       Impact factor: 4.142

3.  Key tissue targets responsible for anthrax-toxin-induced lethality.

Authors:  Shihui Liu; Yi Zhang; Mahtab Moayeri; Jie Liu; Devorah Crown; Rasem J Fattah; Alexander N Wein; Zu-Xi Yu; Toren Finkel; Stephen H Leppla
Journal:  Nature       Date:  2013-08-28       Impact factor: 49.962

4.  MyD88-dependent signaling protects against anthrax lethal toxin-induced impairment of intestinal barrier function.

Authors:  Shu Okugawa; Mahtab Moayeri; Michael A Eckhaus; Devorah Crown; Sharmina Miller-Randolph; Shihui Liu; Shizuo Akira; Stephen H Leppla
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

5.  What is the relevance of lung epithelial cells during the dissemination of spores in inhalational anthrax?

Authors:  Jean-Nicolas Tournier; Aurélie Cleret; Anne Quesnel-Hellmann
Journal:  Infect Immun       Date:  2009-01       Impact factor: 3.441

6.  Cathelicidin administration protects mice from Bacillus anthracis spore challenge.

Authors:  Mark W Lisanby; Melissa K Swiecki; Brian L P Dizon; Kathryn J Pflughoeft; Theresa M Koehler; John F Kearney
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

7.  Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.

Authors:  Matthew A Crawford; Yinghua Zhu; Candace S Green; Marie D Burdick; Patrick Sanz; Farhang Alem; Alison D O'Brien; Borna Mehrad; Robert M Strieter; Molly A Hughes
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

8.  The spore-specific alanine racemase of Bacillus anthracis and its role in suppressing germination during spore development.

Authors:  Olga N Chesnokova; Sylvia A McPherson; Christopher T Steichen; Charles L Turnbough
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

9.  Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant.

Authors:  Brandon Feinen; Nikolai Petrovsky; Anita Verma; Tod J Merkel
Journal:  Clin Vaccine Immunol       Date:  2014-02-19

10.  Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Haijing Hu; Stephen H Leppla; John B Robbins; Rachel Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.